Contineum Therapeutics, Inc. (CTNM)
11.55
-0.03
(-0.26%)
USD |
NASDAQ |
Dec 16, 16:00
11.77
+0.22
(+1.90%)
After-Hours: 20:00
Contineum Therapeutics Market Cap: 298.82M for Dec. 16, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 2.658B |
| Recursion Pharmaceuticals, Inc. | 2.186B |
| CG Oncology, Inc. | 2.886B |
| CEL-SCI Corp. | 17.90M |
| AIM ImmunoTech, Inc. | 1.055M |
Market Cap Related Metrics
| PEG Ratio | -0.0508 |
| Price to Book Value | 1.656 |
| Price | 11.55 |
| Earnings Yield | -19.53% |
| PEGY Ratio | -0.0508 |